Illumina Inc

Change company Symbol lookup

Select an option...

ILMN Illumina Inc

XPEV Xpeng Inc

PTON Peloton Interactive Inc

PEB Pebblebrook Hotel Trust

VFC VF Corp

BWG BrandywineGLOBAL ? Global Income Opportunities Fund

BPYPO Brookfield Property Partners LP

HLAHU Hamilton Lane Alliance Holdings I Inc

GUERF Guerbet SA

BTCM BIT Mining Ltd

Go

--Approach Informed Development of Galleri(R) Multi-Cancer Early Detection Blood Test --Analysis is Part of Extensive and Systematic Comparison of Cancer Specific Cell-Free DNA Features for Multi-Cancer Early Detection (BusinessWire)

Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences: -- Evercore ISI HealthCONx Conference on November 29, 2022Fireside Chat at 8:20am Pacific Time (11:20am Eastern Time) (PR Newswire)

-- Revenue of $1.12 billion for Q3 2022, up 1% from Q3 2021, and up 3% on a constant currency basis -- GAAP diluted loss per share of $(24.26) for Q3 2022, compared to GAAP diluted earnings per share of $2.08 for Q3 2021; GAAP diluted loss per share...(PR Newswire)

The New Board Members Will Bring Industry Experience to Contribute to Company Growth Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology company focused on the development of novel molecular diagnostic testing, recently announced the...(PR Newswire)

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based...(BusinessWire)

-- Panel leverages precision metagenomics to transform testing for urinary tract infections -- Newest kit follows recent launch of panel testing for 66 viral pathogens that pose persistent threats to global public health (PR Newswire)

Illumina, Inc. (NASDAQ: ILMN) today announced that it will host its second annual virtual Environment, Social and Corporate Governance (ESG) focused investor event at 9:30 am Pacific Time (12:30 pm Eastern Time), Friday, October 28, 2022. (PR Newswire)

Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the third quarter 2022 following the close of market on Thursday, November 3, 2022. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, Chief...(PR Newswire)

InvestorsObserver issues critical PriceWatch Alerts for ILMN, TWTR, AAPL, NKE, and HES. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

FinancialNewsMedia.com News Commentary The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing CAGR. Cervical Cancer is a cancer arising from the cervix which is due to the abnormal...(PR Newswire)

New sequencing technologies and capabilities will accelerate the genomic discoveries and clinical insights needed to transform human health Revolutionary NovaSeq X Series sets new benchmark for speed, scale, accuracy, and sustainability (PR Newswire)

InvestorsObserver issues critical PriceWatch Alerts for RIO, LOW, WMT, ILMN, and XOM. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Illumina, Inc. (NASDAQ: ILMN) today announced that its inaugural Illumina Genomics Forum, being held in San Diego from September 28 through October 1, is sold out. To accommodate additional interest, on Thursday, September 29, Illumina will host its...(PR Newswire)

First-of-its-kind Galleri(R) Multi-Cancer Early Detection blood test can screen for multiple cancers through a single blood draw. Henry Ford Health, one of the nation's leading academic medical centers recognized for excellence in clinical care...(PR Newswire)

Illumina, Inc. (Nasdaq: ILMN) will host its 2022 Investor Day on Monday, October 3rd starting at 8:00am Pacific Time in San Diego, CA. The event will feature presentations by members of Illumina's executive team and conclude with a Q&A session. (PR Newswire)

Six startups from Indonesia, Ireland, Israel, South Africa, United Kingdom and the United States will receive seed investment and access to technology and expertise Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based...(PR Newswire)

The panel will generate ideas and inspiration to build the foundational elements needed to make genomic health equitable, informed, and accountable Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today...(PR Newswire)

Illumina, Inc. (NASDAQ:ILMN) today announced that investors, analysts, and other interested parties may view a live webcast of the Innovation Roadmap session of the Illumina Genomics Forum, which will be hosted by Francis deSouza, Chief Executive...(PR Newswire)

Full agenda now available for September 28-October 1 event Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the release of the full agenda for its inaugural Illumina Genomics Forum. The...(PR Newswire)

Illumina, Inc. (NASDAQ:ILMN), today received a decision from the European Commission prohibiting the company's acquisition of GRAIL. The company is reviewing the Commission's order and intends to appeal the decision. The EC decision follows last...(PR Newswire)